3 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 534,642 1,282,686 1,817,328 1,817,328 534,642 xbrli:pure xbrli:shares iso4217:GBP 06848520 2023-04-01 2024-03-31 06848520 2024-03-31 06848520 2023-03-31 06848520 2022-04-01 2023-03-31 06848520 2023-03-31 06848520 2022-03-31 06848520 core:PlantMachinery 2023-04-01 2024-03-31 06848520 core:FurnitureFittings 2023-04-01 2024-03-31 06848520 bus:Director3 2023-04-01 2024-03-31 06848520 bus:Director1 2023-04-01 2024-03-31 06848520 core:PlantMachinery 2023-03-31 06848520 core:FurnitureFittings 2023-03-31 06848520 core:LandBuildings 2024-03-31 06848520 core:PlantMachinery 2024-03-31 06848520 core:FurnitureFittings 2024-03-31 06848520 core:WithinOneYear 2024-03-31 06848520 core:WithinOneYear 2023-03-31 06848520 core:AfterOneYear 2024-03-31 06848520 core:AfterOneYear 2023-03-31 06848520 core:LandBuildings 2023-04-01 2024-03-31 06848520 core:ShareCapital 2024-03-31 06848520 core:ShareCapital 2023-03-31 06848520 core:RetainedEarningsAccumulatedLosses 2024-03-31 06848520 core:RetainedEarningsAccumulatedLosses 2023-03-31 06848520 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 06848520 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-03-31 06848520 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 06848520 core:Non-currentFinancialInstruments 2024-03-31 06848520 core:Non-currentFinancialInstruments 2023-03-31 06848520 core:LandBuildings 2023-03-31 06848520 core:PlantMachinery 2023-03-31 06848520 core:FurnitureFittings 2023-03-31 06848520 bus:Director1 2023-03-31 06848520 bus:Director1 2024-03-31 06848520 bus:Director1 2022-03-31 06848520 bus:Director1 2023-03-31 06848520 bus:Director1 2022-04-01 2023-03-31 06848520 bus:SmallEntities 2023-04-01 2024-03-31 06848520 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 06848520 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 06848520 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 06848520 bus:FullAccounts 2023-04-01 2024-03-31
COMPANY REGISTRATION NUMBER: 06848520
ML DOCTORS LIMITED
Filleted Unaudited Financial Statements
31 March 2024
ML DOCTORS LIMITED
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
£
Fixed assets
Tangible assets
5
120,828
299,319
Investments
6
1,817,328
534,642
------------
---------
1,938,156
833,961
Current assets
Stocks
435,825
350,150
Debtors
7
206,300
184,688
Cash at bank and in hand
26,360
24,631
---------
---------
668,485
559,469
Creditors: amounts falling due within one year
8
532,661
661,079
---------
---------
Net current assets/(liabilities)
135,824
( 101,610)
------------
---------
Total assets less current liabilities
2,073,980
732,351
Creditors: amounts falling due after more than one year
9
63,318
86,734
Provisions
Taxation including deferred tax
323,612
2,941
------------
---------
Net assets
1,687,050
642,676
------------
---------
Capital and reserves
Called up share capital
2
2
Profit and loss account
1,687,048
642,674
------------
---------
Shareholders funds
1,687,050
642,676
------------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
ML DOCTORS LIMITED
Statement of Financial Position (continued)
31 March 2024
These financial statements were approved by the board of directors and authorised for issue on 28 November 2024 , and are signed on behalf of the board by:
M R Zia
Director
Company registration number: 06848520
ML DOCTORS LIMITED
Notes to the Financial Statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Ml House, 9 North Street, Manchester, M8 8RE.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
20% reducing balance
Fixtures and fittings
-
10% reducing balance
Equipment
-
10% reducing balance
R & D
-
25% straight line
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 3 (2023: 3 ).
5. Tangible assets
Land and buildings
Plant and machinery
Fixtures and fittings
Equipment
User defined asset
Total
£
£
£
£
£
£
Cost
At 1 Apr 2023 and 31 Mar 2024
164,356
67,839
76,575
47,461
120,516
476,747
---------
--------
--------
--------
---------
---------
Depreciation
At 1 Apr 2023
61,452
41,570
19,120
55,286
177,428
Charge for the year
1,277
3,501
2,834
6,523
14,135
Disposals
164,356
164,356
---------
--------
--------
--------
---------
---------
At 31 Mar 2024
164,356
62,729
45,071
21,954
61,809
355,919
---------
--------
--------
--------
---------
---------
Carrying amount
At 31 Mar 2024
5,110
31,504
25,507
58,707
120,828
---------
--------
--------
--------
---------
---------
At 31 Mar 2023
164,356
6,387
35,005
28,341
65,230
299,319
---------
--------
--------
--------
---------
---------
6. Investments
Other investments other than loans
£
Cost
At 1 April 2023
534,642
Revaluations
1,282,686
------------
At 31 March 2024
1,817,328
------------
Impairment
At 1 April 2023 and 31 March 2024
------------
Carrying amount
At 31 March 2024
1,817,328
------------
At 31 March 2023
534,642
------------
7. Debtors
2024
2023
£
£
Trade debtors
206,054
184,688
Other debtors
246
---------
---------
206,300
184,688
---------
---------
8. Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
13,361
Trade creditors
360,222
416,231
Corporation tax
27,065
16,609
Social security and other taxes
82,096
132,663
Other creditors
63,278
82,215
---------
---------
532,661
661,079
---------
---------
9. Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
63,318
86,734
--------
--------
10. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Muhammad Ahmad
( 33,187)
( 58)
( 33,245)
--------
----
--------
2023
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Muhammad Ahmad
( 35,187)
2,000
( 33,187)
--------
-------
--------